Participants examined the challenges and opportunities to update oncology drug labeling that is inconsistent with the current evidence base and use in clinical practice. Discussions focused on what sources of information should be considered for labeling updates, the evidentiary standards for labeling updates, and evidence considerations for special populations, such as pediatric oncology. This project, sponsored by the Food and Drug Administration, was conducted by the National Cancer Policy Forum, in collaboration with the Forum on Drug Discovery, Development, and Translation.

For more information on the Forum on Drug Discovery, Development, and Translation, you can visit: https://www.nationalacademies.org/our-work/forum-on-drug-discovery-development-and-translation.